The Pennsylvania House this week did something both smart and politically sensible: it voted to make sure patients know when artificial intelligence is being used to make decisions about their medical care. House Bill 1925 sailed through the chamber 144–59 and now heads to the State Senate. This is about one plain thing — transparency — and it deserves a straightforward, practical response from lawmakers and health providers alike.
What the House actually passed
HB 1925 would require health-care facilities to disclose to patients when AI is used for substantive clinical decision-making. It also forces human review for any benefit termination and protects clinicians who disagree with an AI output from being punished. The bill adds reporting and attestation duties for hospitals and insurers and covers Medicaid and federally funded plans — so it isn’t a tiny change tucked into the margins. Representative Arvind Venkat sponsored the measure and even some Republicans, including Representative Jason Ortitay, voted with Democrats. That bipartisan backing tells you the idea has real legs.
Why transparency is the right first step
Patients have a right to know who — or what — is deciding their care. AI can be helpful, sure, but when algorithms start telling insurers when to deny coverage or when to cut off a treatment, that’s not an abstract tech question. It’s someone’s health on the line. Requiring disclosure is a simple, low-cost guardrail: it doesn’t ban innovation, but it forces accountability and keeps a human in the loop for big decisions. If you’re worried about government overreach, this is the kind of narrow, pro-consumer rule conservatives should support.
The politics: state power vs. federal pressure
The House also passed a resolution telling the White House and the Justice Department to stop threatening states that try to regulate AI. That’s a welcome defense of state authority. Funny thing: President Donald Trump issued an order urging states not to regulate AI, and now a Pennsylvania House with a mix of Republicans and Democrats is pushing back. If anything, this fight should remind us that states can act as labs of practical policy — especially on tech questions where one-size-fits-all federal orders can be clumsy or heavy-handed.
Where this goes next — and what to watch
The bill goes to the State Senate and, if passed, to Governor Josh Shapiro. Expect pushback from some hospitals and tech vendors worried about compliance costs and trade secrets. That’s fair to examine — carve-outs for low-risk tools or FDA-cleared devices are reasonable. But don’t let industry worry-trolling drown out the basic principle: patients should be told when software is effectively making clinical calls about their bodies and money. If the Senate improves the bill without gutting its transparency and human-review bones, Pennsylvanians win.
Bottom line: HB 1925 is a practical, conservative-friendly step toward everyday accountability for AI in health care. It preserves innovation while putting patient notice and human judgment first. That’s not radical. It’s common sense — and in an era of flashy tech promises, common sense deserves a vote of thanks, not a shrug.

